Discordant High Remnant Cholesterol With LDL-C Increases the Risk of Stroke: A Chinese Prospective Cohort Study

Author:

Han Minghui123,Huang Keyong23,Shen Chong14ORCID,Hu Hongyue123,Liu Fangchao23ORCID,Li Jianxin23ORCID,Yang Xueli5,Chen Jichun23ORCID,Liu Xiaoqing6,Cao Jie23,Chen Shufeng23ORCID,Yu Ling7,Zhao Yingxin8,Wu Xianping9,Zhao Liancheng23,Li Ying23,Hu Dongsheng1011ORCID,Huang Jianfeng23ORCID,Lu Xiangfeng23ORCID,Gu Dongfeng12312ORCID

Affiliation:

1. Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, China (M.H., C.S., H.H., D.G.).

2. Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (M.H., K.H., H.H., F.L., J.L., J. Chen, J. Cao, S.C., L.Z., Y.L., J.H., X. Lu, D.G.).

3. Key Laboratory of Cardiovascular Epidemiology (M.H., K.H., H.H., F.L., J.L., J. Chen, J. Cao, S.C., L.Z., Y.L., J.H., X. Lu, D.G.), Chinese Academy of Medical Sciences, Beijing, China.

4. Research Units of Cohort Study on Cardiovascular Diseases and Cancers (C.S.), Chinese Academy of Medical Sciences, Beijing, China.

5. Tianjin Key Laboratory of Environment, Nutrition and Public Health, Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, China (X.Y.).

6. Division of Epidemiology, Guangdong Provincial People’s Hospital and Cardiovascular Institute, Guangzhou, China (X. Liu).

7. Department of Cardiology, Fujian Provincial Hospital, Fuzhou, China (L.Y.).

8. Cardio-Cerebrovascular Control and Research Center, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, China (Y.Z.).

9. Sichuan Center for Disease Control and Prevention, Chengdu, China (X.W.).

10. Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, China (D.H.).

11. Department of Epidemiology and Health Statistics, School of Public Health, Shenzhen University Health Science Center, China (D.H.).

12. School of Medicine, Southern University of Science and Technology, Shenzhen, China (D.G.).

Abstract

BACKGROUND: Previous studies focusing on assessing the effects of remnant cholesterol (RC) and low-density lipoprotein cholesterol (LDL-C) on stroke may not consider their mutual influence. We aimed to explore the associations of RC and discordant high RC with LDL-C with stroke, ischemic stroke (IS), and hemorrhagic stroke. METHODS: This prospective cohort study was conducted based on 3 cohorts of the China-PAR (Prediction for Atherosclerotic Cardiovascular Disease Risk in China) project. RC was calculated as non–high-density lipoprotein cholesterol minus LDL-C estimated by Martin/Hopkins equations. Concordant/discordant categories for RC versus LDL-C were determined based on cut-points of 130 mg/dL for LDL-C and equivalent percentile (32.50 mg/dL) for RC. Cox models were used to estimate adjusted hazard ratios and 95% CIs for incident stroke. RESULTS: Among 113 448 participants recruited at baseline, a total of 98 967 participants were eligible for the final analysis (mean age of 51.44 years; 40.45% were men). During 728 776.87 person-years of follow-up, 2859 stroke cases, 1811 IS cases, and 849 hemorrhagic stroke cases were observed. RC was positively associated with stroke and IS, but not hemorrhagic stroke, with adjusted hazard ratios (95% CIs) of 1.06 (1.02–1.10), 1.09 (1.04–1.13), and 0.95 (0.88–1.03) for per SD increase in RC. Compared with low LDL-C/low RC group, low LDL-C/high RC group had higher risks of stroke (adjusted hazard ratio, 1.15 [95% CI, 1.02–1.30]) and IS (1.19, 1.03–1.38), while high LDL-C/low RC group had no increased risk of stroke (1.07 [0.95–1.20]) and IS (1.09 [0.94–1.25]). CONCLUSIONS: Higher RC was associated with increased risks of stroke and IS but not hemorrhagic stroke. Discordantly high RC, not discordantly high LDL-C, conferred higher risks of stroke and IS. Our findings support further lowering RC by interventions to reduce residual IS risk.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3